Cross Marketing Group Inc. Logo

Cross Marketing Group Inc.

Delivers marketing insights via research and digital solutions using a large Japanese consumer panel.

3675 | T

Overview

Corporate Details

ISIN(s):
JP3272760004
LEI:
Country:
Japan
Address:
新宿区西新宿三丁目20番2号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Established in 2003, Cross Marketing Group Inc. is a comprehensive marketing solutions provider specializing in market research, digital marketing, and data marketing. The company offers a one-stop service for both qualitative and quantitative research, with a core focus on online methodologies. Leveraging one of Japan's largest consumer research panels, it delivers actionable insights to support client decision-making for product development and strategy. The Group's services also encompass a wide range of digital marketing and data-driven solutions, assisting clients in their digital transformation (DX) and marketing process optimization.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-24 08:33
Regulatory News Service
確認書
Japanese 8.9 KB
2025-09-24 08:32
Annual Report
有価証券報告書-第13期(2024/07/01-2025/06/30)
Japanese 1.5 MB
2025-06-24 09:01
Share Issue/Capital Change
臨時報告書
Japanese 33.6 KB
2025-03-04 02:04
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.6 KB
2025-02-14 08:03
Report Publication Announcement
確認書
Japanese 9.0 KB
2025-02-14 08:02
Interim Report
半期報告書-第13期(2024/07/01-2025/06/30)
Japanese 242.4 KB
2025-02-04 03:04
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.6 KB
2025-01-07 03:04
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.2 KB
2024-12-03 03:13
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.3 KB
2024-11-05 02:03
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.5 KB
2024-10-03 08:00
Post-Annual General Meeting Information
臨時報告書
Japanese 27.1 KB
2024-10-02 05:08
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.9 KB
2024-09-27 08:06
Governance Information
内部統制報告書-第12期(2023/07/01-2024/06/30)
Japanese 23.5 KB
2024-09-27 08:06
Registration Form
確認書
Japanese 8.9 KB
2024-09-27 08:05
Annual Report
有価証券報告書-第12期(2023/07/01-2024/06/30)
Japanese 1.5 MB

Automate Your Workflow. Get a real-time feed of all Cross Marketing Group Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cross Marketing Group Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cross Marketing Group Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Eezy Oyj Logo
HR services firm for the full employment lifecycle, from recruitment to freelancer support.
Finland
EEZY
Elicio Therapeutics, Inc. Logo
Develops lymph node-targeted immunotherapies for aggressive, KRAS-driven cancers.
United States of America
ELTX
enCore Energy Corp. Logo
American uranium producer using ISR technology to fuel the U.S. nuclear energy sector.
United States of America
EU
ENERGY FUELS INC Logo
A leading U.S. producer of uranium and rare earth elements for EVs, defense, and technology.
United States of America
UUUU
ENIGMATIG LTD Logo
Global expansion and regulatory compliance consultancy for the financial services industry.
United States of America
EGG
Enjin Co., Ltd. Logo
PR firm for SMEs and medical institutions, offering consulting and a media matching platform.
Japan
7370
Ensol Biosciences Inc. Logo
Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.
South Korea
140610
Enveric Biosciences, Inc. Logo
Develops novel neuroplastogen drugs for severe mental health and addiction disorders.
United States of America
ENVB
Eutilex Co.,Ltd. Logo
Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.
South Korea
263050
Evaxion A/S Logo
Develops AI-powered, personalized vaccines for cancer and infectious diseases.
United States of America
EVAX

Talk to a Data Expert

Have a question? We'll get back to you promptly.